mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |